Growth Hormone Therapy and Brain Tumors

Area of Science:

• Endocrinology
• Neuro-oncology
• Medical Safety

Background:

• Growth hormone (GH) replacement therapy is used for various conditions.
• Concerns exist regarding the potential impact of GH on pre-existing or developing brain tumors.
• Accurate tumor volume assessment relies on Magnetic Resonance Imaging (MRI).

Purpose of the Study:

• To review existing literature on the relationship between GH therapy and brain tumor recurrence, regrowth, or new formation.
• To evaluate the safety of GH replacement therapy in patients with a history of brain tumors.
• To provide evidence-based conclusions on GH therapy's oncogenic potential in the brain.

Main Methods:

• Literature search of studies published after 1990.
• Keywords used included GH, replacement therapy, brain tumor, recurrence, and tumor formation.
• Focus on studies utilizing MRI for accurate sellar lesion volume evaluation.

Main Results:

• GH therapy may lead to tumor enlargement in a very small subset of patients.
• Large-scale research and case-control studies provide reliable confirmation.
• No statistically significant relationship was found between GH therapy and brain tumor recurrence or new formation.

Conclusions:

• GH replacement therapy is considered safe regarding brain tumor recurrence and new formation.
• The risk of GH-induced brain tumor development is minimal and not supported by robust scientific evidence.
• Further large-scale studies reinforce the safety profile of GH therapy in this context.